An alpha4beta1 integrin antagonist decreases airway inflammation in ovalbumin-exposed mice

Eur J Pharmacol. 2009 Jan 28;603(1-3):138-46. doi: 10.1016/j.ejphar.2008.11.063. Epub 2008 Dec 13.

Abstract

Inhibition of the alpha4 subunit of both the alpha4beta1 and alpha4beta7 integrins has shown promise in decreasing airway inflammation and airway hyperresponsiveness in various animal models. We hypothesized that a novel, high-affinity alpha4beta1 antagonist (LLP2A) would decrease the migration of eosinophils to the lung and ameliorate the airway hyperresponsiveness in a mouse model of ovalbumin-induced airway inflammation. To test this hypothesis, we administered LLP2A, or scrambled LLP2A (a negative control), prior to exposure of sensitized BALB/c mice to ovalbumin aerosol. We can partially prevent, or reverse, the airway inflammatory response, but not airways hyperresponsiveness, by treatment of mice with LLP2A, a synthetic peptidomimetic alpha4beta1 antagonist. Specifically engineered, PEGylated (PEG) formulations of this antagonist further reduce the airway inflammatory response to ovalbumin, presumably by improving the circulating half-life of the drug.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Biological Availability
  • Biomarkers / metabolism
  • Bronchoalveolar Lavage
  • Dipeptides / chemistry
  • Dipeptides / pharmacokinetics
  • Dipeptides / pharmacology*
  • Dipeptides / therapeutic use
  • Exhalation
  • Goblet Cells / drug effects
  • Goblet Cells / metabolism
  • Inflammation / chemically induced*
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Inflammation / pathology
  • Integrin alpha4beta1 / antagonists & inhibitors*
  • Lung / drug effects
  • Lung / metabolism
  • Lung / pathology
  • Lung / physiopathology
  • Lung Compliance / drug effects
  • Male
  • Mice
  • Nitrates / metabolism
  • Nitric Oxide / metabolism
  • Nitrites / metabolism
  • Ovalbumin / toxicity*
  • Oxidative Stress
  • Phenylurea Compounds / chemistry
  • Phenylurea Compounds / pharmacokinetics
  • Phenylurea Compounds / pharmacology*
  • Phenylurea Compounds / therapeutic use
  • Polyethylene Glycols / chemistry
  • Respiratory System / drug effects*
  • Respiratory System / metabolism
  • Respiratory System / pathology
  • Respiratory System / physiopathology

Substances

  • Biomarkers
  • Dipeptides
  • Integrin alpha4beta1
  • LLP2A compound
  • Nitrates
  • Nitrites
  • Phenylurea Compounds
  • Nitric Oxide
  • Polyethylene Glycols
  • Ovalbumin